SCHEMBL7731373

SCHEMBL7731373

[2H]C([2H])([2H])N(C([2H])([2H])C#CC)[C@]([2H])(C([2H])([2H])[2H])C([2H])([2H])c1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Selegiline SCHEMBL7722148 0.84 MAOB (0.38)
Selegiline SCHEMBL7722145 0.78 MAOB (0.48)
Selegiline SCHEMBL7722421 0.77 MAOB (0.42)
Selegiline SCHEMBL7722635 0.77 MAOB (0.42)
Selegiline SCHEMBL7729341 0.74 MAOB (0.53)
Selegiline SCHEMBL7727405 0.72 MAOB (0.44)
Selegiline SCHEMBL7729024 0.71 MAOB (0.53)
Selegiline SCHEMBL7729368 0.68 MAOB (0.42)
Selegiline SCHEMBL7727757 0.68 MAOB (0.49)
Selegiline SCHEMBL7729586 0.67 MAOB (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286124-A1 PROP-2-YN-1-AMINE INHIBITORS OF MONOAMINE OXIDASE TYPE B AUSPEX PHARMACEUTICALS, INC. (US) 2010-11-11 US disclosed